Skip to main content

Table 2 chemotherapy combined with trastuzumab

From: Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

  Patients (N = 299)
Taxane 146(48.8%)
Vinorelbine 33(11%)
Gemcitabine 75(25.1%)
Cisplatin 60(20.1%)
Pemetrexed 8(2.7%)
Carboplatin 6(2%)
Capecitabine 71(23.7%)